ArticleWorld journal of gastroenterology2024

Erlotinib combination with a mitochondria-targeted ubiquinone effectively suppresses pancreatic cancer cell survival.

Pui-Yin Leung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.